Kurzbezeichnung Titel Prüfteam Status
MMY3008 A phase III study comparing Daratumumab, Lenalidomide and Dexamethasone (DRd) versus Lenalidomide and Dexamethasone (Rd) in Subjects with previously untreated Multiple Myeloma who are ineligible for High Dose Therapy Prof. Krauter Rekrutierung beendet